Clinical trial Recruiting at 1 site Interventional Ages 18 to 40 Women only

Precision acupuncture and lifestyle for PCOS

Official title: MulticenterClinical Study of Intelligent and Precise Acupuncture and Lifestyle Interventions for Polycystic Ovary Syndrome Guided by Multimodal With Ocular Diagnosis

Run by Peking University Third Hospital · NCT07809503 · Data updated 2026-11-12

This trial tests whether a precision acupuncture approach combined with a personalized lifestyle plan helps improve insulin resistance in people with PCOS compared with conventional acupuncture and standard lifestyle changes.

Quick facts

Study typeInterventional
Ages18 Years to 40 Years
SexWomen only
Enrollment210 (estimated)
SponsorPeking University Third Hospital
Academic / other
Locations2 sites (Beijing, Beijing Municipality and 1 other locations)
StatusRecruiting
StartedJuly 10, 2026
Main results expectedDecember 31, 2028
Study endsDecember 31, 2028
Registry record updatedSeptember 9, 2026
Trial IDNCT07809503 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18–40 with BMI 25–40 kg/m² meeting at least two Rotterdam criteria for PCOS.

Probably not a fit

Individuals with other causes of hyperandrogenism, renal/hepatic impairment, autoimmune disease, malignancy, type 1 diabetes, or recent medications affecting study outcomes may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, multicenter, parallel-group randomized trial in adults with PCOS. Participants will be assigned to either model-guided precision acupuncture plus personalized lifestyle interventions or conventional acupuncture plus standard lifestyle changes, with 12 weeks of treatment and risk monitoring guided by traditional Chinese medicine diagnostics. Primary outcome is change in HOMA-IR, with secondary endpoints covering endocrine and metabolic markers, menstrual/ovulatory outcomes, psychological well-being, quality of life, safety, and health-economic impact. The study aims to establish an intelligent, individualized management model for PCOS based on multimodal risk assessment. Results will inform whether the precision approach offers superior metabolic and reproductive benefits over standard care.

Why it matters

Potential benefit: If successful, the approach could offer better insulin resistance control and broader health improvements for people with PCOS.

How similar studies have gone: Prior studies in PCOS and integrative therapies have shown potential benefits, but this specific precision acupuncture with multimodal risk monitoring is novel/experimental.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged18-40 years, inclusive.
* Body mass index (BMI) of 25-40 kg/m², inclusive.
* Meeting the 2003 Rotterdam diagnostic criteria for polycystic ovary syndrome (PCOS), defined by the presence of at least two of the following three criteria: Oligo-ovulation or anovulation; Clinical and/or biochemical signs of hyperandrogenism; Polycystic ovarian morphology on ultrasonography.
* Willing to participate voluntarily in the study, able to understand the study procedures, and able to provide written informed consent.

Exclusion Criteria:

* Presence of hyperandrogenemia due to other causes, such as hyperprolactinemia, thyroid disorders, congenital adrenal hyperplasia, or exogenous androgen use.
* Presence of renal disease (creatinine clearance \<60 mL/min), hepatic impairment, autoimmune disease, or malignancy.
* Type 1 diabetes mellitus or glycated hemoglobin (HbA1c) \>53 mmol/mol (7%). - Use, within the past 3 months, of medications that may affect study assessments, including glucocorticoids, insulin, glucose-lowering agents such as acarbose, antidepressants, hormonal contraceptives, ovulation-inducing agents, or other relevant medications.
* Blood pressure \>160/100 mmHg.
* Currently pregnant or breastfeeding, pregnancy within the past 6 months, or planning to become pregnant during the study period.
* Having received continuous acupuncture treatment for at least 2 months prior to study treatment.
* Daily smoking or alcohol consumption.
* Presence of language barriers, psychiatric disorders, or other conditions that may impair the participant's ability to understand the study, comply with the intervention, or complete follow-up assessments.

Where it's running

  • Peking University Third Hospital
    Beijing, Beijing Municipality, China
    Recruiting
  • Beijing Haidian Hospital
    Beijing, Beijing Municipality, China
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.